Form 10-K VERACYTE, INC. For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Veracyte, Inc (VCYT) PT Lowered to $35 at Needham & Company
March 1, 2022 6:29 AM ESTNeedham & Company analyst Mike Matson lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $35.00 (from $55.00) while maintaining a Buy rating.
The analyst commented, "VCYT's 4Q21 revenue and EPS beat consensus. Organic revenue growth (excluding estimated revenue from Decipher and HalioDx... More
